# COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability

> **NCT05584189** · NA · COMPLETED · sponsor: **MP Biomedicals, LLC** · enrollment: 99 (actual)

## Conditions studied

- Sars-CoV-2 Infection
- COVID-19

## Interventions

- **DEVICE:** Rapid SARS-CoV-2 Antigen Test

## Key facts

- **NCT ID:** NCT05584189
- **Lead sponsor:** MP Biomedicals, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-07
- **Primary completion:** 2021-10-27
- **Final completion:** 2021-10-27
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2023-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05584189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05584189, "COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05584189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*